You can't make an omelet...

Whitehead biologist Rudolf Jaenisch spoke at Thomas Jefferson University in Philadelphia this Friday sharing with an audience of about 300 his thoughts on nuclear reprogramming (http://www.the-scientist.com/2005/4/25/13/1), and the promise of therapeutic cloning. Consistent with his former arguments and testimony before congress in 2001, he argued that human reproductive cloning is dangerous to the extent that it could be considered impossible. From this, he reasoned that critics worried about

Written byBrendan Maher
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Whitehead biologist Rudolf Jaenisch spoke at Thomas Jefferson University in Philadelphia this Friday sharing with an audience of about 300 his thoughts on nuclear reprogramming (http://www.the-scientist.com/2005/4/25/13/1), and the promise of therapeutic cloning. Consistent with his former arguments and testimony before congress in 2001, he argued that human reproductive cloning is dangerous to the extent that it could be considered impossible. From this, he reasoned that critics worried about the destruction of viable human embryos during traditional routes to embryonic stem cells should have less to argue about with regards to stem cell lines created by somatic cell nuclear transfer. A fertilized embryo does have the potential to develop into a normal human baby whereas a cloned embryo does not. Nevertheless, Jaensich said he is hopeful that researchers can limit the use of egg cells in creating clonal totipotent stem cell lines. If only they can recapitulate the nuclear reprogramming that occurs during somatic cell nuclear transfer, the need for egg cells can be obviated, presumably skirting any reasonable bioethical arguments. But that may be a big presumption, and groups such as Jaenisch?s will never be able understand the complex reprogramming steps without doing the SCNT experiments in mammalian (including human) egg cells.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies